Meet our team and listen to our sponsored talk by Reinhold Horlacher, PhD, from trenzyme, on Wednesday, 11 November at 12:35 CET.

Our team

Talk: High-Yield Production of SARS-CoV-2 Proteins: From Small Scale Transfection to GMP Compliant Process.

To support research groups for development of serological tests, generation of high-affinity antibodies and new vaccine candidates, trenzyme has developed a platform for rapid production of high-quality recombinant SARS-CoV-2 proteins by transient transfection, high-producer cell lines and even GMP compliant production cell lines for development of the intranasal vaccine XPOVAX.

Presented by Reinhold Horlacher, PhD, Managing Director at trenzyme.

Wednesday, 11 November at 12:35 CET.


General information

Registration link for virtual event: click here